Peginterferon lambda-1a

DB14767Investigational

Peginterferon lambda-1a is under investigation in clinical trial NCT01754974 (Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C).

Mechanism: Pharmacologically active on Interferon lambda receptor 1
Curator reviewed
Code names: BMS-914143

Resolves to

Compound

UNII0T0250N43UCAS914617-98-4

Targets

Q8IU57IFNLR1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

14Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Peginterferon lambda-1a, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account